Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
02/2006
02/07/2006US6994843 Delivery of stimulants through an inhalation route
02/07/2006CA2340202C Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors
02/07/2006CA2311344C 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
02/07/2006CA2262454C Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha.
02/07/2006CA2221075C Use of aminoalcohol derivatives in the treatment of liver disease
02/07/2006CA2200433C Phenyloxazolidinone antimicrobials
02/07/2006CA2026147C Cytotoxic agents comprising maytansinoids and their therapeutic use
02/06/2006CA2511314A1 Novel recombinant t4 phage particle and uses thereof
02/02/2006WO2006011670A1 PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE
02/02/2006WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor
02/02/2006WO2006010756A1 Oxazolidinone compounds and compositions and methods related thereto
02/02/2006WO2005067906A3 Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol
02/02/2006WO2004100877A3 Vaccine accelerator factor (vaf) for poultry
02/02/2006WO2002094990A3 Receptors and membrane-associated proteins
02/02/2006US20060025594 Small molecule entry inhibitors
02/02/2006US20060025432 N-[2-[(3-Chloro-2-fluorobenzyl)thio]-6-[(2-hydroxy-1-methylethyl)amino]-4-pyrimidinyl]- 4-morpholinesulfonamide; asthma, antiallergens; rhinitis, chronic obstructive pulmonary disease, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis
02/02/2006US20060025428 Bicyclic heteroaromatic compounds as kinase inhibitors
02/02/2006US20060025423 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma
02/02/2006US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/02/2006US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
02/02/2006US20060025384 adding organic solvent and dissolivng adefovir dipivoxil ultrasonically to form solution, and spray drying; have different melting points, solubility, and density
02/02/2006US20060025374 Novel oligoribonucleotide derivatives for specific inhibition of gene expression
02/02/2006US20060025357 Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus
02/02/2006US20060025356 28-epirapalogs
02/02/2006US20060025332 Cross-linked glycopeptide-cephalosporin antibiotics
02/02/2006US20060024792 G-protein coupled receptors
02/02/2006US20060024754 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
02/02/2006US20060024666 Humanized antibodies against the venezuelan equine encephalitis virus
02/02/2006US20060024659 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
02/02/2006US20060024393 Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases
02/02/2006US20060024330 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
02/02/2006US20060024329 Recombinant live vaccine based on canine herpesvirus, in particular against Carre's disease, rabies or the parainfluenza virus type 2.
02/02/2006US20060024323 Active immunization using a siderophore receptor protein
02/02/2006US20060024318 Vaccination with immuno-isolated cells producing an immunomodulator
02/02/2006US20060024307 For treatment and prevention of acute and chronic infectious diseases, mostly of viral etiology, and for producing an immunomodulating effect; comprising a homeopathically potentised form of monoclonal, polyclonal, or natural antibody to gamma interferon, does not suppress the activity of the interferon
02/02/2006US20060024293 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha
02/02/2006US20060024267 TNFr/OPG-like molecules and uses thereof
02/02/2006US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors
02/02/2006DE19856463B4 Retrovirale, mit LCMV pseudotypisierte Hybrid-Vektoren Retroviral pseudotyped with LCMV hybrid vectors
02/02/2006DE102004034744A1 Rendering T-lymphocyte-attacking viruses harmless in the human body, especially for treating AIDS and related disorders, using menadione or derivative to induce selective oxidative death of T-lymphocytes
02/02/2006DE102004034623A1 Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 6-formyl-tetrahydropteridines, processes for their preparation and their use as medicaments
02/02/2006DE102004032439A1 Verwendung von Extrakten aus Wurzeln von Pelargonium sidoides und Pelargonium reniforme The use of extracts from roots of Pelargonium sidoides and Pelargonium reniforme
02/02/2006CA2617188A1 Antimicrobial and/or antiviral composition and to methods for preparing and administering same
02/02/2006CA2581693A1 New use
02/02/2006CA2575272A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies
02/02/2006CA2574959A1 Antimicrobial peptides derived from cap18
02/02/2006CA2574668A1 Oxazolidinone compounds and compositions and methods related thereto
02/02/2006CA2574308A1 Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors
02/02/2006CA2574307A1 Rifamycin derivatives for treating microbial infections
02/02/2006CA2574301A1 (r/s) rifamycin derivatives, their preparation and pharmaceutical compositions
02/01/2006EP1621635A2 Self-assembling recombinant HP16 papillomavirus capsid proteins
02/01/2006EP1621623A2 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitis
02/01/2006EP1621554A1 Immunoglobulins devoid of light chains
02/01/2006EP1621540A1 Nitrogen-containing heterocyclic compounds and use thereof
02/01/2006EP1621205A1 Antimicrobial peptides derived from CAP18
02/01/2006EP1621076A1 Synergistic microbicidal combination
02/01/2006EP1620545A2 Disease prevention and vaccination following thymic reactivation
02/01/2006EP1620445A2 Method and compositions for identifying anti-hiv therapeutic compounds
02/01/2006EP1620433A1 Oxazolidinone derivatives as antimicrobials
02/01/2006EP1620126A2 Disease prevention and vaccination prior to thymic reactivations
02/01/2006EP1620098A1 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
02/01/2006EP1547613A4 Medication and method for treating pathological syndrome
02/01/2006EP1430144A4 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
02/01/2006EP1235812B1 Pyrimidine derivatives as selective inhibitors of cox-2
02/01/2006EP1225874B1 Antiviral solid dispersions
02/01/2006EP1200479B1 Multiple cytokine-antibody complexes
02/01/2006EP1194409B1 Pyrazolidinol compounds
02/01/2006EP1146894B1 Uses of thank protein, a tnf homologue, to inhibit growth of tumour cells
02/01/2006EP1115849B1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
02/01/2006EP1080078B1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
02/01/2006EP1064402B1 Antisense modulation of lfa-3
02/01/2006EP1047448B1 Dna vaccines against tick-borne flaviviruses
02/01/2006EP1028750B1 Method for preparing multivalent vaccines
02/01/2006EP1001804B1 Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections
02/01/2006EP0956040B1 Stimulation of host defense mechanisms against viral challenges
02/01/2006EP0906119B1 Stimulation of host defense mechanisms against cancer
02/01/2006EP0898478B1 Stimulation of host defence mechanisms against tumors
02/01/2006EP0835313B1 Omp26 antigen from haemophilus influenzae
02/01/2006CN1729200A Macrolides
02/01/2006CN1729186A Piperidine derivatives useful as CCR5 antagonists
02/01/2006CN1727489A Bacterial plasmids
02/01/2006CN1727359A Compound from catarrh mollase bacterial
02/01/2006CN1727347A Methylene containing aminobeterocycle substitutional cephalosporin of amidinothioacetamide, preparation method and application
02/01/2006CN1727346A Derivant of gamma carbon alkenyl cephalosporin, preparing method and application
02/01/2006CN1727345A Derivant of Deacetoxy cephalosporanicacid, preparation and application
02/01/2006CN1727344A Derivant of cephalosporin of amidinothioacetamide, preparation method and application
02/01/2006CN1727337A Compound in 4,4-dibasic-3,4-dihydro-2(1H) quinazolone category
02/01/2006CN1727325A Compound of butenafine hydrochloride, preparation method, and application as medication for restraining and killing fungus
02/01/2006CN1727015A Imipenem/cilastatin powder for injection, and transfusion preparation device of three chamber for dissolving dissolvants
02/01/2006CN1726995A Pure liquid herbal extracts for treating AIDS, and preparation method
02/01/2006CN1726981A Antivirus medical broth of compound Neilupaer
02/01/2006CN1726979A Sustained release preparation of root of indian stringbush
02/01/2006CN1726973A Chinese materia medica preparation for treating hepatitis b virus
02/01/2006CN1726971A Areca pellets for clearing away the lung-heat
02/01/2006CN1726970A Antibiotic anti-inflammatory medical-herb stuffed pillows, and preparation method
02/01/2006CN1726960A Combination of effective parts for curing chronic hepatitis, preparation and usage
02/01/2006CN1726958A Chinese material medica preparation in use for treating infection of influenza virus, and preparation method
02/01/2006CN1726951A Medical adhibition in use for treating cold, and production method
02/01/2006CN1726937A Yuganning capsule
02/01/2006CN1726936A Formula of Chinese traditional medicine for treating mastitis and tuberculosis